Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

Hyaluronic acid fillers and combination treatments significantly improve facial defects from autoimmune diseases and are well-tolerated.

Faulty inflammasome activation may lead to autoimmune skin diseases and could be a target for new treatments.

Activating autophagy in dogs with certain diseases improves their skin and hair.

Women with PCOS often have more hair growth, skin darkening, and acne, which are linked to hormonal and metabolic issues.

The document concludes that various treatments for skin conditions are effective, but some require further research, and certain factors like gender and lifestyle can influence disease outcomes.

Almost all patients with chronic kidney disease not yet on dialysis have at least one skin problem.

Skin problems are very common in people with end-stage kidney disease.

The COVID-19 pandemic led to an increase in untreated hair diseases and showed the importance of teledermatology.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

Higher Claudin 3 levels in the blood are linked to more severe alopecia areata.

Lupus can cause unusual vision problems, so it's important to consider it in such cases.

Early recognition and treatment of severe SLE symptoms can improve outcomes.

The main difference in hair loss for lupus patients is smaller and fewer sebaceous glands.

Thalidomide works best for skin lupus not helped by antimalarials, but has many side effects; other treatments are less effective, especially if patients also have systemic lupus.

Macrophage activation syndrome can be a deadly first sign of systemic lupus erythematosus.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Lenalidomide effectively and safely treats skin symptoms in pediatric lupus, reducing the need for prednisone.

The document concludes that while white skin, nail, and mucosa diseases increase skin cancer risk, they are generally harmless, especially compared to darker pigmentation conditions.

Excessive hair loss can be an early sign of celiac disease.

Certain skin conditions in women are linked to higher risks of metabolic syndrome and type 2 diabetes due to hormone imbalances.

Some skin conditions may increase the risk of heart disease, and understanding their connection could lead to better treatments.

Hair loss was the first sign of a brain-related complication in a woman with lupus, and early treatment helped her hair grow back.

Skin diseases are common and can significantly affect people's lives; better outcome measures and ethical clinical trials are needed to improve dermatology care.

Non-scarring hair loss is common in lupus patients and can be diagnosed with specific hair and tissue tests.

Fibroblasts are crucial for tissue repair and inflammation, and understanding them can help treat fibrotic diseases.

People with Lichen Planus, especially with mucosal involvement, are more likely to have Metabolic Syndrome, which increases their risk for heart disease and diabetes.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.